Sientra, Inc. (NASDAQ:SIEN) released its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.55) earnings per share for the quarter, beating the consensus estimate of ($0.59) by $0.04, Morningstar.com reports. Sientra had a negative return on equity of 45.60% and a negative net margin of 148.22%. The company had revenue of $8.20 million for the quarter, compared to analyst estimates of $6.97 million. The firm’s quarterly revenue was up 32.3% on a year-over-year basis.

Shares of Sientra (NASDAQ SIEN) traded down 6.74% on Thursday, hitting $10.37. The stock had a trading volume of 477,581 shares. The firm’s market capitalization is $198.21 million. Sientra has a 12-month low of $6.92 and a 12-month high of $11.47. The company has a 50 day moving average of $10.40 and a 200-day moving average of $8.92.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Cannell Capital LLC boosted its position in shares of Sientra by 2.3% in the first quarter. Cannell Capital LLC now owns 1,139,571 shares of the medical instruments supplier’s stock worth $9,595,000 after buying an additional 26,000 shares during the period. Segantii Capital Management Ltd boosted its position in shares of Sientra by 574.1% in the first quarter. Segantii Capital Management Ltd now owns 18,200 shares of the medical instruments supplier’s stock worth $153,000 after buying an additional 15,500 shares during the period. Blair William & Co. IL boosted its position in shares of Sientra by 2.0% in the first quarter. Blair William & Co. IL now owns 30,758 shares of the medical instruments supplier’s stock worth $299,000 after buying an additional 594 shares during the period. KCG Holdings Inc. purchased a new position in shares of Sientra during the first quarter worth about $147,000. Finally, Gilder Gagnon Howe & Co. LLC boosted its position in shares of Sientra by 17.2% in the first quarter. Gilder Gagnon Howe & Co. LLC now owns 817,609 shares of the medical instruments supplier’s stock worth $6,884,000 after buying an additional 120,226 shares during the period. 77.80% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Sientra, Inc. (NASDAQ:SIEN) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS” was first posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/sientra-inc-nasdaqsien-releases-quarterly-earnings-results-beats-expectations-by-0-04-eps/1471093.html.

Several equities research analysts have recently weighed in on SIEN shares. Zacks Investment Research lowered Sientra from a “hold” rating to a “sell” rating in a research note on Wednesday, May 17th. Lake Street Capital started coverage on Sientra in a research note on Monday, April 17th. They issued a “buy” rating and a $11.00 price objective on the stock. Stephens started coverage on Sientra in a research note on Tuesday, July 11th. They issued an “overweight” rating and a $12.00 price objective on the stock. Finally, ValuEngine upgraded Sientra from a “sell” rating to a “hold” rating in a research note on Thursday, June 22nd. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $13.50.

Sientra Company Profile

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Earnings History for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.